Cancer continues to be a major health problem in the world. During 2018, there were 9.6 million deaths and 18.1 million new cases registered across the globe. It is estimated that one in 5 men and one in 6 women will develop cancer during their lifetime. This disease kills one in 8 men and one in 11 women. Developing countries have seen an increase in cancer occurrence and change in type of cancers due to change in social and economic conditions. The objective of this research was to further evaluate 1659 specimens for anatomical pathology testing. The data was collected from the records of the pathological anatomy laboratory at the Mohamed V Hospital in Meknes, Morocco. It is one-year study period (January-December 2013). Results of the anatomy pathology exam showed cancer positive for 9.6% of specimens; inconclusive for 1%; and negative for 66.2%. For all specimens, the most analyzed organs are breast with 29.7%; skin with 21.3%; cervical with 2.6%. For cancer patients, the most affected organs are skin (21.3%) and breast (29.7%). For cancer patients, Neoplasm is present in 9.3% of patients. Patients with metastatic cancer represent 0.3%. Patients with non-neoplastic lesions represent 66.2%. 1% of patients represent uncertain results. Additional immunohistochemistry research is needed before conclusive recommendations are made.
References
[1]
El Hilali, H., El Hilali, F., Samih, M. and Laziri, F. (2017) Cancer Incidence in Northern Central Moroccan Patients. Journal of Multidisciplinary Social Research, 4, 403-409.
[2]
Association Lalla Salma de lutte contre le Cancer (2012) Registre des cancers de la région du Grand Casablanca.
[3]
American Cancer Society (2015) Cancer Facts & Figures American Cancer Society, Inc., Atlanta, GA.
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html
[4]
Hecht, S.S. (2012) Lung Carcinogenesis by Tobacco Smoke. International Journal of Cancer, 131, 2724-2732. https://doi.org/10.1002/ijc.27816
[5]
Mu, L. and Mukamal, K.J. (2016) Alcohol Consumption and Rates of Cancer Screening: Is Cancer Risk Overestimated? Cancer Causes & Control, 27, 281-289.
https://doi.org/10.1007/s10552-015-0692-3
[6]
Cialdella-Kam, L., Sabado, P., Bernstein, L., Bispeck, K., Hawk, E., Krawiec, V., O’Donnell, J.F. and Silverman, S. (2012) Implementing Cancer Prevention into Clinical Practice. Journal of Cancer Education, 27, 136-149.
https://doi.org/10.1007/s13187-012-0331-6
[7]
Ngan, H.Y.S., Garland S.M., Bhatla, N., Pagliusi, S.R., Chan, K.K.L., Cheung, A.N.Y., Chu, T.Y., Domingo, E.J., Qiao, Y.L., Park, J.S., Tay, E.H. and Supakarapongku, W. (2011) Asia Oceania Guidelines for the Implementation of Programs for Cervical Cancer Prevention and Control. Journal of Cancer Epidemiology, 2011, Article ID: 794861. https://doi.org/10.1155/2011/794861
[8]
Kim, H.W. and Kim, D.H. (2015) Awareness of Cervical Cancer Prevention among Mothers of Adolescent Daughters in Korea: Qualitative Research. BMJ Open, 5, e006915. https://doi.org/10.1136/bmjopen-2014-006915
[9]
Bouchbika, Z., Haddad, H., Benchakroun, N., Eddakaoui, H., Kotbi, S., Megrini, A., Bourezgui, H., Sahraoui, S., Corbex, M., Harif, M. and Benider, A. (2013) Cancer Incidence in Morocco: Report from Casablanca Registry 2005-2007. The Pan African Medical Journal, 16, 31. https://doi.org/10.11604/pamj.2013.16.31.2791
[10]
Registre Canadien du Cancer (2015) Réseau canadien des Centres de données de recherche. https://crdcn.org/fr/datasets/ccr-canadian-cancer-registry
[11]
Guerrero, A.M., Genuino, A.J., Santillan, M., Praditsitthikorn, N., Chantarastapornchit, V., Teerawattananon, Y., Alejandria, M. and Toral, J.A. (2015) A Cost-Utility Analysis of Cervical Cancer Screening and Human Papillomavirus Vaccination in the Philippines. BMC Public Health, 15, 730.
https://doi.org/10.1186/s12889-015-2046-1
[12]
Stewart, B.W. and Wild, C.P. (2014) World Cancer Report 2014. World Health Organization. http://www.who.int/
[13]
Institute National du Cancer (INCa) (2014) Les cancers en France. Institut national du Cancer, France.
[14]
Galceran, J., Ameijide, A., Carulla, M., Mateos, A., Quirós, J.R., Rojas, D., Alemán, A., Torrella, A., Chico, M., Vicente, M., Díaz, J.M., Larrañaga, N., Marcos-Gragera, R., Sánchez, M.J., Perucha, J., Franch, P., Navarro, C., Ardanaz, E., Bigorra, J., Rodrigo, P. and Bonet, R.P. (2017) Cancer Incidence in Spain, 2015. Clinical and Translational Oncology, 19, 799-825. https://doi.org/10.1007/s12094-016-1607-9
[15]
Hou, S.I. and Cao, X. (2019) A Cross-Sectional Study of Cancer Knowledge and Beliefs among Faith-Based Chinese in the USA versus Taiwan. Journal of Preventive Medicine & Public Health, 52, 60-65. https://doi.org/10.3961/jpmph.17.051
[16]
Organisation Mondiale de la Santé (2013) Dernières statistiques mondiales sur le cancer en augmentation à 14,1 millions de nouveaux cas en 2012: L’augmentation marquée du cancer du sein demande des réponses. Centre Internationale des Recherche sur le Cancer.
[17]
Wellings, E., Vassiliades, L. and Abdalla, R. (2016) Breast Cancer Screening for High-Risk Patients of Different Ages and Risk—Which Modality Is Most Effective? Cureus, 8, e945. https://doi.org/10.7759/cureus.945
[18]
Escrich, E., Solanas, M. and Moral, R. (2014) Olive Oil and Other Dietary Lipids in Breast Cancer. In: Zappia, V., Panico, S., Russo, G., Budillon, A. and Della Ragione, F., Eds., Advances in Nutrition and Cancer. Cancer Treatment and Research, Springer, Berlin, Heidelberg, 289-309.
https://doi.org/10.1007/978-3-642-38007-5_17
[19]
American Cancer Society (2017) Breast Cancer Facts & Figures 2017-2018. American Cancer Society, Inc., Atlanta, GA.
[20]
Maddams, J., Brewster, D., Gavin, A., Steward, J., Elliott, J., Utley, M. and Møller, H. (2009) Cancer Prevalence in the United Kingdom: Estimates for 2008. British Journal of Cancer, 101, 541-547. https://doi.org/10.1038/sj.bjc.6605148
[21]
N’Dah, K.J., Doukoure, B., Troh, E., Aman, N.A., Koffi, K.E., Kouamé, A.D., Effi, A.B., D’Horpock, A.F. and Diomande, M.I.J. (2014) Epidemiological and Histological Aspects of Women Genital Cancers in Côte d’Ivoire. Open Journal of Obstetrics and Gynecology, 4, 516-523. https://doi.org/10.4236/ojog.2014.49073
[22]
Engbang, J.P.N., Koh, V.M., Tchente, C.N. and Fewou, A. (2015) Histo-Epidemiological Aspects of Genital Cancers in Women in the Littoral Region, Cameroon. The Pan African Medical Journal, 21, 116.
[23]
Castañón, A., Landy, R., Cuzick, J. and Sasieni, P. (2014) Cervical Screening at Age 50 - 64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population Based Case Control Study. PLoS Medicine, 11, e1001585.
https://doi.org/10.1371/journal.pmed.1001585
https://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&from_uid=23820257
